Table 2 Achievement of Glycemic Control by Study Design and Treatment Modality
From: Oral hypoglycemic agents: do the ends justify the means?
| Â | Design | Patient No. Oral/Insulin | Oral type | Well control Oral / Insulin | Comparison of control |
|---|---|---|---|---|---|
Langer’00 [3] | RCT | 201 / 203 | glyburide | 82 % vs. 88 % | similar |
Lain’09 [50] | RCT | 41 / 41 | glyburide | 91 % vs. 97 % | similar |
Bertini’05 [51] | RCT | 24 / 27 | glyburide | 79 % | similar |
Ogunyemi’07 [52] | RCT | 48 / 49 | glyburide | 93 % | similar |
Tempe’13 [53] | RCT | 32 / 32 | glyburide | 91 % vs. 94 % | similar |
Silva’07 [54] | RCT | 36 / 36 | glyburide | --- | similar |
Rowen’09 [4] | RCT | 363 / 370 | metformin | 54 % | for Metformin |
Moore’07 [32] | RCT | 31 / 32 | metformin | MBG | similar |
Spaulonci,’13 [55] | RCT | 47 / 47 | metformin | 74 % | similar |
Tertti’13 [16] | RCT | 110 / 107 | metformin | 79 % | similar |
Niromanesh’12 [56] | RCT | 80 / 80 | metformin | 86 % | similar |
Ijas’11 [57] | RCT | 50 / 50 | metformin | 68 % | similar |
Ramos’07 [43] | Retrospective | 122 | glyburide | 84 % | for glyburide |
Jacobson’05 [58] | Retrospective | 236 /268 | glyburide | 86 % vs. 63 % | dissimilar |
Conway’04 [37] | Retrospective | 75 | glyburide | 84 % | similar |
Yogev’10 [38] | Retrospective | 124 | glyburide | 75 % | similar |
Rochon’06 [39] | Retrospective | 101 | glyburide | 81 % | similar |
Kahn’06 [40] | Retrospective | 95 | glyburide | 81 % | similar |